Untitled Document Euroscicon News
Search
About Euroscicon News

Euroscicon host unbiased events where scientists from many fields can participate and offer their own experiences of technology that can help improve the experiments of others. Each event is an opportunity for industry and academia to share discussion, new bonds and new ideas for the future.

This site is a listing of news from Euroscicon plus information from our partners and friends. It contains current information on selected events, details of our prize draw winners, press releases about new reagents and technologies, job offers and information on occasional discounted registrations. 

The best news is that anyone subscribed to our e-newsletter will automatically receive the articles posted to this website directly in their inbox.

We are constantly changing and improving this website so please do come back and if you would like us to post an article, event announcement or job description do get in touch

View Article  Recombinant vaccines - right molecule, right place, right time? – 12th March 2010
"Huge technological advances have been made recently in the genomic and post-genomic analyses of pathogens and disease. To exploit these advances for the production of successful recombinant vaccines we need strategies to select appropriate molecules and to deliver them appropriately to stimulate protective immune responses. This meeting will explore both candidate discovery and the tools for delivering vaccines effectively". Meeting Chair: Dr Alasdair Nisbet, Moredun Research Institute, UK. The meeting has CPD approval.   more »
View Article  Free Subscription to Feed International
Feed International is a business journal for people involved in the feed industry internationally.   more »
View Article  Regulatory T cells in inflammatory and infectious diseases: new horizons for old friends - 5th March, 2010
"This meeting will provide an update on phenotypic and functional aspects of regulatory T cells, aiming to inform, educate and entertain. Presentations will be delivered by world-class leaders in their respective fields and a lively discussion will follow each series of talks. Coupled with the pleasant ambience and modern facilities of the venue, this event promises to be one not to be missed" Meeting Chair: Dr Oliver Garden,The Royal Veterinary College & Imperial College London, UK. The meeting has CPD approval.   more »
View Article  Asterand Announces Collaborative Agreement to Characterise Antibodies
Asterand plc (LSE: ATD), a leading provider of human tissue and services to scientists engaged in drug discovery research, announces that it has entered into a collaborative agreement with Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue. Asterand will undertake the validation and characterisation of a selected group of Abcam antibodies for immuno-histochemistry applications using Asterand’s PhaseZERO® Human Tissue Services platform.   more »
View Article  What to get a scientist who has just had a baby?
It's so difficult to know what to get a colleague at the special time in their lives.   more »
View Article  Antimicrobial Peptides: New challenges for Science – November 27th 2009
The agenda for this event is under construction. If you have any queries or are interested in speaking at this event please contact meetingsproducer@euroscicon.com. The meeting has CPD approval   more »
View Article  Small Scale Bio-production: Beyond the Flask.- 24th November 2009.
"Once you can produce it in a flask, what next? The focus of this meeting will be on techniques for the bioproduction of usable quantities of biologic materials, specifically recombinant proteins, monoclonal antibodies, cytokines viruses and other secreted cellular products from eukaryotic cells. Topics covered will include expression systems, mammalian vs. insect vs. other, constituitive vs. transient expression, cell culture medium considerations and culture devices for scale-up that can be used in any laboratory. This meeting should show the fastest pathway from discovery to proof of principle and the production of 100 mgs to several grams of product" Meeting Chair: Dr John J.S. Cadwell, President and CEO, FiberCell Systems Inc, USA. The meeting has CPD approval.   more »